CEO Corner

  1. From CRO Executive To Biopharma CEO 3/1/2022

    Taking over the CEO position of a biopharma in the midst of COVID, I was faced with many unique challenges. While I continue to work through these challenges, I’ve developed guidelines that have played a pivotal role in navigating such transitions.

  2. The Key To Competitive Differentiation In Life Sciences Is People 2/1/2022

    Especially in the early stage of a company, where speed and accuracy of drug development are highly valued, focusing on organizational strategies that provide differentiation enables a company to position itself as innovative.

  3. What I Learned In A French Lab That Led To My Role As A CEO 2/1/2022

    Our innovations didn’t happen overnight. From the very beginning, we knew that we would need to partner with others to be successful.

  4. Embracing Culture As A Strategic Business Asset 1/4/2022

    I believe that my recognition of the role company culture plays in shaping an organization has contributed to my success as my career advanced into leadership roles.

  5. Is It A Great Business Opportunity Or Merely A Great Idea? 11/1/2021

    When entrepreneurs are presented with a biotech idea, they must distinguish between those that are merely exciting in concept and those with the potential to be actually developed into a company.

  6. Skills I Learned That Have Helped Me As A Public Pharma CEO 10/1/2021

    While I learned a great deal about the industry in the latter part of my career, as a leader, my foundation was molded by the valuable lessons learned in two very different spaces — the U.S. Army Reserve and nursing.

  7. Creating A Culture of Innovation In Any Size Organization 9/1/2021

    A company’s size and culture play a large role in how it defines and executes innovation.

  8. What The Sale Of Agios' Oncology Pipeline Taught Me 8/2/2021

    Anytime a company undergoes organizational change — even if it’s a good change — the road there is not necessarily an easy one. I’d like to share a few things that might make it — or any major decision — easier for you

  9. How European Biopharmas Can Benefit From Establishing A U.S. Presence 8/2/2021

    The maturity and scale of the biotech industry in the U.S. can offer several competitive advantages, making expansion into the U.S. well worth considering for leaders of biopharma companies formed in other countries, such as across Europe.

  10. Against All Odds: Advancing From R&D To Phase 3 7/1/2021

    There is nothing more rewarding than knowing that we can help save a life and give hope to patients and their friends and families. Because lives are at stake, there must be more regulations and processes to ensure safety and efficacy.